Betaine and choline status modify the effects of folic acid and creatine supplementation on arsenic methylation in a ran

  • PDF / 1,009,262 Bytes
  • 14 Pages / 595.276 x 790.866 pts Page_size
  • 116 Downloads / 171 Views

DOWNLOAD

REPORT


ORIGINAL CONTRIBUTION

Betaine and choline status modify the effects of folic acid and creatine supplementation on arsenic methylation in a randomized controlled trial of Bangladeshi adults Anne K. Bozack1,2   · Caitlin G. Howe2,3   · Megan N. Hall4,5,6 · Xinhua Liu7 · Vesna Slavkovich2 · Vesna Ilievski2 · Angela M. Lomax‑Luu2 · Faruque Parvez2 · Abu B. Siddique8 · Hasan Shahriar8 · Mohammad N. Uddin8 · Tariqul Islam8 · Joseph H. Graziano2 · Mary V. Gamble2  Received: 24 March 2020 / Accepted: 28 August 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020

Abstract Purpose  Methylation of ingested inorganic arsenic (InAs) to monomethyl- (MMAs) and dimethyl-arsenical species (DMAs) facilitates urinary arsenic elimination. Folate and creatine supplementation influenced arsenic methylation in a randomized controlled trial. Here, we examine if baseline status of one-carbon metabolism nutrients (folate, choline, betaine, and vitamin ­B12) modified the effects of FA and creatine supplementation on changes in homocysteine, guanidinoacetate (GAA), total blood arsenic, and urinary arsenic metabolite proportions and indices. Methods  Study participants (N = 622) received 400 or 800 μg FA, 3 g creatine, 400 μg FA + 3 g creatine, or placebo daily for 12 weeks. Results  Relative to placebo, FA supplementation was associated with greater mean increases in %DMAs among participants with betaine concentrations below the median than those with levels above the median (FDR